Evidence map›Paper›PMID 41768827›Full record

ArticleAnalytical science advances2026

Monitoring of Metabolic Disorders Through Electro-Sensing of Riboflavin by Novel Super-Conductive Silver Ink Modified Paper.

Rokhsareh Ebrahimi, Mohammad Hasanzadeh, Nasrin Shadjou

Abstract read
In one paragraph

Article in Analytical science advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Rokhsareh EbrahimiNutrition Research Center Tabriz University of Medical Sciences Tabriz Iran.
Mohammad HasanzadehPharmaceutical Analysis Research Center Tabriz University of Medical Sciences Tabriz Iran.
Nasrin ShadjouDepartment of Nanotechnology Faculty of Chemistry Urmia University Urmia Iran.ORCID https://orcid.org/0000-0001-5961-3686

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Riboflavin (RIB), or vitamin B2, plays a key role in cellular protection against oxidative stress, and its deficiency can cause severe physiological complications, including metabolic disorders, photosensitivity, anaemia, growth delay and gastrointestinal problems. Rapid and accurate quantification of RIB in real biological samples is important. In this study, a novel paper-based electrochemical microsensor was fabricated for RIB detection in blood plasma samples. Highly conductive silver ink was synthesized and loaded into a ballpoint pen, enabling direct drawing of microscale (∼85.78 µm) electrodes onto a cellulose substrate. Owing to the optimized ink formulation, the drawn electrodes dried immediately (∼3 s) at room temperature, producing uniform, well-defined and highly conductive patterns without spreading. In the presence of induced stress conditions, the electrodes exhibited excellent thermal, mechanical and moisture stability, with resistances remaining stable at 1.5 Ω (at 150°C), 2.9 Ω (humidity exposure) and 2 Ω (mechanical bending). The three-dimensional network formed by silver ink on photographic paper substrate preserved conductivity under stress and prevented structural cracking. RIB was detected using cyclic voltammetry, square-wave voltammetry, chronoamperometry and differential pulse voltammetry. Under optimized conditions, the sensor showed a linear response over 0.4-10 µM with a lower limit of quantification of 0.4 µM. Intra-day and inter-day repeatability ranged from 1.47% to 6.35% and 3.4% to 8.04%, respectively.

Indexed as

bioanalysiselectroconductive inkmetabolic disorders paper‐based sensorsriboflavin

Identifiers

PMID41768827
PMCPMC12948650

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.